1. Home
  2. Stocks
  3. Metropolis Share Price
  • Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Metropolis Healthcare Share Price

    Mid Cap
    ₹2,140.95
    + 1.65 (0.08%)
    • Advice
    • Hold
    09 September, 2024 14:10 BSE: 542650 NSE: METROPOLIS ISIN: INE112L01020

    Start SIP in Metropolis Healthcare

    Start SIP

    Metropolis Healthcare Performance

    Day Range

    • Low 2,115
    • High 2,158
    ₹ 2,140

    52 Week Range

    • Low 1,360
    • High 2,190
    ₹ 2,140
    • Open Price2,115
    • Previous Close2,139
    • Volume45191

    Metropolis Healthcare Chart

    • Over 1 Month + 3.64%
    • Over 3 Month + 6.93%
    • Over 6 Month + 31.13%
    • Over 1 Year + 50.73%

    Metropolis Healthcare Key Statistics

    P/E Ratio 80.1
    PEG Ratio -84.3
    Market Cap Cr
    Price to Book Ratio 10
    EPS 22.5
    Dividend 0.2
    Relative Strength Index 57.73
    Money Flow Index 60.72
    MACD Signal 17.03
    Average True Range 62.53

    Metropolis Healthcare F&O

    Metropolis Healthcare Futures Metropolis Healthcare Option Chain

    Metropolis Healthcare Investment Rating

    • Master Rating:

    • Metropolis Healthcare has an operating revenue of Rs. 1,243.97 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 21 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Metropolis Healthcare Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 286292269285256264
    Operating Expenses Qtr Cr 218218211218198197
    Operating Profit Qtr Cr 687459675868
    Depreciation Qtr Cr 252524212022
    Interest Qtr Cr 565666
    Tax Qtr Cr 101381198
    Net Profit Qtr Cr 313227312640
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,1151,087
    Operating Expenses Annual Cr 845797
    Operating Profit Annual in Cr 258269
    Depreciation Cr 9185
    Interest Annual Cr 2227
    Tax Annual Cr 4240
    Net Profit Annual Cr 116139
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 269238
    Cash from Investing Activity Annual Cr -8147
    Cash from Financing Annual Activity Cr -183-288
    Net Cash Flow Annual Cr 5-3
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,031936
    Fixed Assets Annual Cr 1,1201,085
    Total Non Current Assets Annual Cr 1,2001,169
    Total Current Assets Annual Cr 272265
    Total Assets Annual Cr 1,4731,434
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 201183
    ROE Annual % 1115
    ROCE Annual % 1517
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2527
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 313331291309277283
    Operating Expenses Qtr Cr 235251226234214212
    Operating Profit Qtr Cr 798065756370
    Depreciation Qtr Cr 262625222123
    Interest Qtr Cr 565666
    Tax Qtr Cr 13141012108
    Net Profit Qtr Cr 383627352933
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,2171,163
    Operating Expenses Annual Cr 925860
    Operating Profit Annual in Cr 283288
    Depreciation Cr 9489
    Interest Annual Cr 2327
    Tax Annual Cr 4644
    Net Profit Annual Cr 128143
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 264247
    Cash from Investing Activity Annual Cr -8947
    Cash from Financing Annual Activity Cr -181-292
    Net Cash Flow Annual Cr -72
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,096988
    Fixed Assets Annual Cr 722685
    Total Non Current Assets Annual Cr 1,2391,199
    Total Current Assets Annual Cr 316303
    Total Assets Annual Cr 1,5551,502
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 215193
    ROE Annual % 1214
    ROCE Annual % 1517
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2426
    Invest in Metropolis Healthcare

    Metropolis Healthcare Technicals

    EMA & SMA

    Current Price
    ₹2,140.95
    + 1.65 (0.08%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹2,099.17
    • 50 Day
    • ₹2,055.94
    • 100 Day
    • ₹1,975.72
    • 200 Day
    • ₹1,848.29
    • 20 Day
    • ₹2,088.09
    • 50 Day
    • ₹2,066.82
    • 100 Day
    • ₹1,973.59
    • 200 Day
    • ₹1,817.34

    Metropolis Healthcare Resistance and Support

    PIVOT
    ₹2,152.95
    Resistance
    First Resistance 2,175.90
    Second Resistance 2,212.50
    Third Resistance 2,235.45
    RSI 57.73
    MFI 60.72
    MACD Single Line 17.03
    MACD 21.08
    Support
    First Support 2,116.35
    Second Support 2,093.40
    Third Supoort 2,056.80

    Metropolis Healthcare Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 165,321 5,526,681 33.43
    Week 122,240 4,119,495 33.7
    1 Month 142,623 4,345,733 30.47
    6 Month 269,586 8,872,085 32.91

    Metropolis Healthcare Result Highlights

    Metropolis Healthcare Synopsis

    NSE-Medical-Services

    Metropolis Healthcar is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1103.43 Cr. and Equity Capital is Rs. 10.25 Cr. for the Year ended 31/03/2024. Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798.
    Market Cap 10,962
    Sales 1,133
    Shares in Float 2.56
    No of funds 167
    Yield 0.19
    Book Value 10.63
    U/D Vol ratio 1.3
    LTDebt / Equity 3
    Alpha 0.09
    Beta 0.81

    Metropolis Healthcare Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 49.62%49.67%49.74%49.74%
    Mutual Funds 23.67%21.31%16.01%14.02%
    Insurance Companies 3.49%3.29%4.27%2.4%
    Foreign Portfolio Investors 18.25%18.9%21.66%24.29%
    Individual Investors 4.07%5.24%6.63%7.78%
    Others 0.9%1.59%1.69%1.77%

    Metropolis Healthcare Management

    Name Designation
    Dr. Sushil Kanubhai Shah Chairman & Executive Director
    Mrs. Ameera Sushil Shah Managing Director
    Mr. Hemant Sachdev Non Exe.Non Ind.Director
    Mr. Vivek Gambhir Independent Director
    Mr. Sanjay Bhatnagar Independent Director
    Ms. Anita Ramachandran Independent Director
    Mr. Subramanian Ranganathan Independent Director
    Dr. Aparna Rajadhyaksha Non Exe.Non Ind.Director

    Metropolis Healthcare Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Metropolis Healthcare Corporate Action

    Date Purpose Remarks
    2024-08-10 Quarterly Results
    2024-05-21 Audited Results
    2024-02-02 Quarterly Results
    2023-11-04 Quarterly Results & Interim Dividend
    2023-08-02 Quarterly Results
    Date Purpose Remarks
    2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
    2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
    2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
    2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

    Metropolis Healthcare MF Shareholding

    Name Amount(cr)
    HDFC Flexi Cap Fund Growth 61,572
    Nippon India Small Cap Fund - Growth 60,373
    Kotak Equity Arbitrage Fund Growth 51,570
    SBI Arbitrage Opportunities Fund Regular Growth 32,415
    UTI Flexi Cap Fund Regular Plan Growth 27,053

    Metropolis Healthcare FAQs

    What is Share Price of Metropolis Healthcare ?

    Metropolis Healthcare share price is ₹2,140 As on 09 September, 2024 | 13:56

    What is the Market Cap of Metropolis Healthcare ?

    The Market Cap of Metropolis Healthcare is ₹10970.6 Cr As on 09 September, 2024 | 13:56

    What is the P/E ratio of Metropolis Healthcare ?

    The P/E ratio of Metropolis Healthcare is 80.1 As on 09 September, 2024 | 13:56

    What is the PB ratio of Metropolis Healthcare ?

    The PB ratio of Metropolis Healthcare is 10 As on 09 September, 2024 | 13:56

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.